Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
BC-1471 is a selective antagonist of deubiquitinase STAM-binding protein (STAMBP) which decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism
though it may also have an anti-angiogenic effect
Body weight measurement and analysis reveal that the mice treated with WZB117 lost about 1 to 2 grams of body weight compared with the mock-treated mice with most of the weight loss in the fat tissue
vegetables
InChi: InChI=1S/C20H17FN2O4S/c1-13-10-15(14-6-3-2-4-7-14)11-18(19(13)21)20(25)22-23-28(26
SN-38 Size:Solid 2 mg BC-1471 is a selective antagonistSN 38 is the active metabolite of irinotecan (an analog of camptothecin a topoisomerase I inhibitor); it is 1000 times more active than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN 38 relative to irinotecan varies from 2 to 2000 fold. SN38 is metabolized via glucoronidation by UGT1A1. The variant of UGT1A1 in ~10% of Caucasians which leads to poor metabolization of irinotecan predicts irinotecan toxicity, as it cannot be
US$ 55.00
US$ 105.00
US$ 45.00
US$ 35.00
US$ 140.00
US$ 170.00
US$ 120.00
US$ 125.00